ACCCBUZZ BLOG

The newest Oncology Issues is here, opening the year with a spotlight on the six 2025 ACCC Innovators: Fox Chase Cancer Center, Lifepoint Health, Penn Medicine Princeton Health, WellSpan Cancer Institute, Highlands Oncology, and Shaw Cancer Center.

The August 2025 edition of Oncology Issues contains 8 feature articles covering the full spectrum of cancer care, from financial health to mental well-being support for providers.

In recognition of patients' struggle to navigate a fragmented health care system throughout their cancer treatment, the NCCN hosted a policy summit dedicated to strengthening coordination between primary care providers and oncologists.

In support of the need for more advanced Digital Health Technologies, ACCC partnered with DiMe to create comprehensive resources that support the development of trustworthy CRS de-risking products.

By leveraging machine learning algorithms, natural language processing, and data analytics, AI accelerates the identification of potential drug candidates, optimizes preclinical and clinical testing, and reduces costs.

Despite substantial advances in screening, diagnosis, and treatment, notable disparities exist in oncology that often result in delayed diagnoses, suboptimal treatment, poor outcomes, and undertreatment of pain in certain racial and ethnic groups.

By leveraging modern health care technologies and data-driven insights, AI and machine learning have the potential to enhance screening, diagnosis, and personalized treatment strategies across multiple cancer types.

In an attempt to enhance patient access, comfort, and convenience while achieving institutional cost savings, the Froedtert & Medical College of Wisconsin Blood and Marrow Transplant and Cellular Therapy Program expanded its offerings by introducing autologous transplants as an outpatient service.

By thoughtfully and responsibly incorporating AI into our practices, we can enhance our ability to deliver care that is not only more personalized and effective but also deeply compassionate, across every type of cancer program.

Since 2022, the introduction of 6 additional T cell–engaging bispecific antibodies has transformed the therapeutic landscape across several oncologic, hematologic, and ophthalmologic indications. These approvals catalyzed a need for institutions to develop operational processes that would ensure safe and effective delivery of these novel therapeutics.

Lung cancer remains the leading cause of cancer-related death in the United States, accounting for more fatalities than colorectal and pancreatic cancer combined. One of the keys to improving clinical outcomes lies in early detection and intervention, especially for incidental lung nodules, which could be an early indicator of lung cancer.

The Affordable Connectivity Program ends today, leaving 1 in 6 American households without access to high-speed internet.

ACCC recently announced a collaboration with the Digital Medicine Society on a project to develop a risk prediction tool for cytokine release syndrome.

Discover highlights from the Oncology Practice Transformation and Integration Center preconference at #AMCCBS.

ACCCBuzz engaged in a discussion Josiah Allen, PharmD, a clinical pharmacogenomic pharmacist and Jake Barnes, an IS application manager, both from St. Elizabeth Healthcare in Kentucky, focused on the obstacles encountered in integrating a biomarker testing add-on module in their EHR.

Explore key takeaways from a meeting between ACCC, Inova Schar Cancer Institute, and delegates from the Swedish Ministry of Health and Social Affairs.

Highlights from the second day of the ACCC 50th Annual Meeting & Cancer Center Business Summit (#AMCCBS).

ACCCBuzz spoke with the co-directors of a precision medicine Initiative at the Sidney Kimmel Cancer Center at Jefferson Health in Philadelphia, Pennsylvania about their work in building a team to champion EHR integration to support precision medicine.

BeiGene hosted its second annual Talk About It: Cancer and Mental Health LinkedIn Live event. This year’s theme focused on bridging cancer centers and community partners to help meet acute needs.

In recognition of January as Cervical Health Awareness Month, ACCCBuzz highlights cervical cancer among the American Indian and Alaska Native population.

This is the second post of a three-part series on Modern Healthcare’s Social Determinants of Health Symposium.

Sutter Health details innovative programs designed to drive health equity at the most recent Modern Healthcare Social Determinants of Health Symposium.

For their final policy summit of 2023, the NCCN invited multidisciplinary stakeholders to Washington D.C. for a discussion focused on patients with cancer receiving comprehensive and equitable care.

This cancer program adapted the University of Washington’s Collaborative Care model to embed counseling services into oncology and palliative care across six clinic locations. This model allows patients to receive counseling for depression, anxiety, or other psycho-social concerns while in active treatment and survivorship, eliminating many barriers to care.